Human Genome Epidemiology Literature Finder
|
Records 1 - 20 (of 20 Records) |
| Query Trace: Myelodysplastic Syndromes and JAK2[original query] |
|---|
| MPL W515L mutation in Chinese patients with myeloproliferative diseases. Leukemia & lymphoma 2008 May 49 (5): 955-8. Xu Wei, Li Jian-Yong, Xia Jun, Zhang Su-Jiang, Fan Lei, Qiao Ch |
| JAK2 V617F patients with essential thrombocythemia present with clinical features of polycythemia vera. Leukemia & lymphoma 2008 Apr 49 (4): 696-9. Zhang Sujiang, Qiu Hongxia, Fischer Bruce S, Li Weida, Duan Limin, Sun Xuemei, Xu Wei, Li Jianyo |
| Mutation in TET2 in myeloid cancers. The New England journal of medicine 2009 May 360 (22): 2289-301. Delhommeau François, Dupont Sabrina, Della Valle Véronique, James Chloé, Trannoy Severine, Massé Aline, Kosmider Olivier, Le Couedic Jean-Pierre, Robert Fabienne, Alberdi Antonio, Lécluse Yann, Plo Isabelle, Dreyfus François J, Marzac Christophe, Casadevall Nicole, Lacombe Catherine, Romana Serge P, Dessen Philippe, Soulier Jean, Viguié Franck, Fontenay Michaela, Vainchenker William, Bernard Olivier |
| Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC cancer 2010 10 (1): 401. Rocquain Julien, Carbuccia Nadine, Trouplin Virginie, Raynaud Stéphane, Murati Anne, Nezri Meyer, Tadrist Zoulika, Olschwang Sylviane, Vey Norbert, Birnbaum Daniel, Gelsi-Boyer Véronique, Mozziconacci Marie-Joel |
| ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. British journal of haematology 2010 Nov 151 (4): 365-75. Gelsi-Boyer Véronique, Trouplin Virginie, Roquain Julien, Adélaïde José, Carbuccia Nadine, Esterni Benjamin, Finetti Pascal, Murati Anne, Arnoulet Christine, Zerazhi Hacène, Fezoui Hacène, Tadrist Zoulika, Nezri Meyer, Chaffanet Max, Mozziconacci Marie-Joëlle, Vey Norbert, Birnbaum Dani |
| Screening for hotspot mutations in PI3K, JAK2, FLT3 and NPM1 in patients with myelodysplastic syndromes. Clinics (São Paulo, Brazil) 2011 66 (5): 793-9. Machado-Neto João Agostinho, Traina Fabiola, Lazarini Mariana, Campos Paula de Melo, Pagnano Katia Borgia Barbosa, Lorand-Metze Irene, Costa Fernando Ferreira, Saad Sara T Olal |
| TET2 deletions are a recurrent but rare phenomenon in myeloid malignancies and are frequently accompanied by TET2 mutations on the remaining allele. British journal of haematology 2012 Jan 156 (1): 67-75. Bacher Ulrike, Weissmann Sandra, Kohlmann Alexander, Schindela Sonja, Alpermann Tamara, Schnittger Susanne, Kern Wolfgang, Haferlach Torsten, Haferlach Claud |
| Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromes. Haematologica 2013 Dec 98 (12): 1856-64. Fernandez-Mercado Marta, Burns Adam, Pellagatti Andrea, Giagounidis Aristoteles, Germing Ulrich, Agirre Xabier, Prosper Felipe, Aul Carlo, Killick Sally, Wainscoat James S, Schuh Anna, Boultwood Jacqueli |
| SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
| Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 May 27 (5): 681-9. Fu Bin, Jaso Jesse M, Sargent Rachel L, Goswami Maitrayee, Verstovsek Srdan, Medeiros L Jeffrey, Wang Sa |
| The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia. Human pathology 2014 Dec 45 (12): 2471-9. Federmann Birgit, Abele Manuel, Rosero Cuesta David Santiago, Vogel Wichard, Boiocchi Leonardo, Kanz Lothar, Quintanilla-Martinez Leticia, Orazi Attilio, Bonzheim Irina, Fend Fal |
| Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing. American journal of hematology 2016 Feb . Patnaik Mrinal M, Lasho Terra L, Finke Christy M, Hanson Curtis A, King Rebecca L, Ketterling Rhett P, Gangat Naseema, Tefferi Ayal |
| Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. The American journal of surgical pathology 2018 Mar . Gur Hatice D, Loghavi Sanam, Garcia-Manero Guillermo, Routbort Mark, Kanagal-Shamanna Rashmi, Quesada Andres, Khogeer Haitham, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop, Khoury Joseph |
| Clonal hematopoiesis of indeterminate potential-associated mutations and risk of comorbidities in patients with myelodysplastic syndrome. Cancer 2019 3 125 (13): 2233-2241. Naqvi Kiran, Sasaki Koji, Montalban-Bravo Guillermo, Alfonso Pierola Ana, Yilmaz Musa, Short Nicholas, Assi Rita, Jabbour Elias, Ravandi Farhad, Kadia Tapan, Pierce Sherry, Takahashi Koichi, Nogueras Gonzalez Graciela, Kanagal-Shamanna Rashmi, Patel Keyur, Soltysiak Kelly A, Kantarjian Hagop M, Garcia-Manero Guiller |
| Mutation status and burden can improve prognostic prediction of patients with lower-risk myelodysplastic syndromes. Cancer science 2019 Dec . Jiang Lingxu, Luo Yingwan, Zhu Shuanghong, Wang Lu, Ma Liya, Zhang Hua, Shen Chuying, Yang Wenli, Ren Yanling, Zhou Xinping, Mei Chen, Ye Li, Xu Weilai, Yang Haiyang, Lu Chenxi, Jin Jie, Tong Hongy |
| Clinicopathologic characterisation of myeloid neoplasms with concurrent spliceosome mutations and myeloproliferative-neoplasm-associated mutations. Journal of clinical pathology 2020 3 73 (11): 728-736. Liu Yen-Chun, Illar Gwendolyn M, Bailey Nathanael Gl |
| Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2-mutated neoplasms. Leukemia 2020 12 35 (8): 2371-2381. Todisco Gabriele, Creignou Maria, Gallì Anna, Guglielmelli Paola, Rumi Elisa, Roncador Marco, Rizzo Ettore, Nannya Yasuhito, Pietra Daniela, Elena Chiara, Bono Elisa, Molteni Elisabetta, Rosti Vittorio, Catricalá Silvia, Sarchi Martina, Dimitriou Marios, Ungerstedt Johanna, Vannucchi Alessandro Maria, Hellström-Lindberg Eva, Ogawa Seishi, Cazzola Mario, Malcovati Lu |
| Comprehensive analysis of genetic factors predicting overall survival in Myelodysplastic syndromes. Scientific reports 2022 4 12 (1): 5925. Maurya Nehakumari, Mohanty Purvi, Dhangar Somprakash, Panchal Purvi, Jijina Farah, Mathan S Leo Prince, Shanmukhaiah Chandrakala, Madkaikar Manisha, Vundinti Babu R |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. Blood cancer journal 2023 9 13 (1): 149. Talha Badar, Yenny A Moreno Vanegas, Ahmad Nanaa, James M Foran, Aref Al-Kali, Abhishek Mangaonkar, Hemant Murthy, Hassan B Alkhateeb, David Viswanatha, Rong He, Mithun Shah, Cecilia Arana Yi, Mark R Litzow, Naseema Gangat, Ayalew Tefferi, Mrinal M Patna |
| Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study. Journal of hematology & oncology 2023 4 16 (1): 37. Zhang Tao, Auer Paul, Dong Jing, Cutler Corey, Dezern Amy E, Gadalla Shahinaz M, Deeg H Joachim, Nazha Aziz, Carlson Karen-Sue, Spellman Stephen, Bolon Yung-Tsi, Saber Wa |
- Page last reviewed:Feb 1, 2024
- Content source: